Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04758702 · ClinicalTrials.gov registry record · Phase 1
The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing.
A Phase 1 study of Lack of Keratinized Gingiva, sponsored by Abdo Y Ismail.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04758702: Completed Phase 1 study of Lack of Keratinized Gingiva, sponsored by Abdo Y Ismail.
NCT04758702 is a Phase 1 study of Lack of Keratinized Gingiva that has completed, run by Abdo Y Ismail. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04758702, a Phase 1 study of Lack of Keratinized Gingiva, has completed, sponsored by Abdo Y Ismail.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A Randomized, Three Parallel Arms Clinical Trial to evaluate s the clinical impact of L-PRF vs H-PRF vs Palatal stent on the healing of the donor palatal site.
Primary Outcome
The primary outcome is to asses the percentage of re-epithelization of the palatal donor site and assess primary wound healing.
Conditions Studied
Interventions
- BIOLOGICAL L-PRF (Leucocyte- platelet rich fibrin)
- BIOLOGICAL H-PRF (Horizontal -platelet rich fibrin)
- DEVICE Surgical stent
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2023-05-25 |
| Phase | Phase 1 |
What the finished NCT04758702 record still lists
NCT04758702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Lack of Keratinized Gingiva appearing as the primary indexed condition, and to 3 interventions - of which L-PRF (Leucocyte- platelet rich fibrin) is the first listed.
NCT04758702 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04758702 about?
NCT04758702 is a clinical study titled "The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing.". A Randomized, Three Parallel Arms Clinical Trial to evaluate s the clinical impact of L-PRF vs H-PRF vs Palatal stent on the healing of the donor palatal site.
What is the current status of trial NCT04758702?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2021-02-24. Estimated completion is 2023-05-25.
What conditions does trial NCT04758702 study?
This clinical trial studies the following conditions: Lack of Keratinized Gingiva.
What interventions are being tested in trial NCT04758702?
The interventions under investigation include: L-PRF (Leucocyte- platelet rich fibrin) (BIOLOGICAL), H-PRF (Horizontal -platelet rich fibrin) (BIOLOGICAL), Surgical stent (DEVICE).
Who is sponsoring clinical trial NCT04758702?
This trial is sponsored by Abdo Y Ismail, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04758702 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lack of Keratinized Gingiva
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04758702's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI